en · de · es · fr · pt
selank-notes.peptides1126.com › Topic › Stability, Handling, And Analytical Control — 2026 Update

Stability, Handling, And Analytical Control — 2026 Update

By Editorial Desk · published 2025-11-03 · last reviewed 2025-11-19 · Topic

If you have been reading about electrospray ionization and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2025-11-19. Where a claim depends on a specific study, the study is described rather than over-claimed.

Stability, Handling, and Analytical Control

Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.

Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.

Selank Background And Chemical Identity

Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.

The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.

Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.

Selank at a glance

PropertyValueNotes
Dry storage temperature-20 C or belowSealed, desiccated, protected from light
Solution stabilityHours to days at 2-8 CDepends on buffer and microbial load
Preferred pH rangeNear neutral to slightly acidicAlkaline pH accelerates hydrolysis
Main degradation routesHydrolysis and deamidationNo cysteine or methionine in sequence
Identity confirmationElectrospray mass spectrometryObserved mass compared with 751.9 Da

Analytical Methods and Stability

Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.

Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.

Related pages on this site

Storage, Analysis, and Regulatory Status

Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Selank Origin and Chemical Identity

Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.

The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.

Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.

Administration, Testing and Availability

Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.

Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.

Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.

Notes from published material

=== Digital ion trap === The digital ion trap (DIT) is a quadrupole ion trap (linear or 3D) that differs from conventional traps by the driving waveform. A DIT is driven by digital signals, typically rectangular waveforms that are generated by switching rapidly between discrete voltage levels. Major advantages of the DIT are its versatility and virtually unlimited mass range. The digital ion trap has been developed mainly as a mass analyzer.

The Berlin Crisis of 1961 was the last major incident in the Cold War regarding the status of Berlin and post–World War II Germany. By the early 1950s, the Soviet approach to restricting emigration movement was emulated by most of the rest of the Eastern Bloc. However, hundreds of thousands of East Germans annually emigrated to free and prosperous West Germany through a "loophole" in the system that existed between East Berlin and West Berlin. The emigration resulted in a massive "brain drain" from East Germany to West Germany of younger educated professionals, such that nearly 20% of East Germany's population had migrated to West Germany by 1961. That June, the Soviet Union issued a new ultimatum demanding the withdrawal of Allied forces from West Berlin. The request was rebuffed, but the United States now limited its security guarantees to West Berlin. On 13 August, East Germany erected a barbed-wire barrier that would eventually be expanded through construction into the Berlin Wall, effectively closing the loophole and preventing its citizens from fleeing to the West.

== Process == Sake kasu is created during the sake brewing process. When koji, a type of fungus used for sake brewing, is added to steamed rice, it releases amylase enzyme. This enzyme breaks down the rice starch, creating sugar. After that, yeast is added to the mixture, transforming the sugar into alcohol. Finally, the fermented rice mash is compressed and the sake is drawn out of the mash. The residue that remains behind from the process is called sake kasu. Sake brewer Todd Bellomy estimates that in his brewery, 250 liters of sake kasu are produced as a by-product of every 700 liters that of sake that they produce. The weather conditions during rice growing can affect the production of sake kasu. In high temperatures, the starch inside the rice grain has a less soluble structure. This boosts the amount of sake kasu and reduces the taste of Japanese sake due to the reduction of the solubility of the rice. In contrast, when the weather is cooler, the rice grains are finer, and the solubility is higher. Thus, creating less sake kasu and the taste of Japanese sake will be stronger.

Sources: en.wikipedia.org

Further detail

=== Gray baby syndrome === Intravenous chloramphenicol use has been associated with the so-called gray baby syndrome. This phenomenon occurs in newborn infants because they do not yet have fully functional liver enzymes (i.e. UDP-glucuronyl transferase), so chloramphenicol remains unmetabolized in the body. This causes several adverse effects, including hypotension and cyanosis. The condition can be prevented by using the drug at the recommended doses, and monitoring blood levels.

Harassment and bullying are persistent problems, particularly when they relate to discriminatory conduct. Harassment is unlawful based on similar protected characteristics as general equal treatment rights in different statutes, although there is not yet a single coherent codification of standards. Disability Discrimination Act 1992 For example, under the Sex Discrimination Act 1984 section 28A, sexual harassment means conduct of a sexual nature, that is unwelcome, where a 'reasonable person' would have been offended, humiliated or intimidated'. This is also unlawful under the Australian Human Rights Commission Act 1986 section 3, and enables courts to pay compensate for loss or damage. Under section 28B it is unlawful for a person to sexually harass their employee, and employers are vicariously liable for conduct of any employee to another where a breach is "in connection with" employment. For example, in Richardson v Oracle Corporation Australia Pty Ltd the Federal Court awarded $130,000 in compensation for persistent sexual slurs against the claimant, who was forced to resign from her job, up from $18,000 given at first instance. In South Pacific Restor Hotels v Trainor an employer was held liable for harassment after work hours, but in accommodation provided by the employer. However employers may avoid liability if they have taken "all reasonable steps" to prevent harassment, which will usually mean swift action after a complaint.

=== Relationships and marriages === While in her late teens, Kidder became pregnant via a boyfriend, who arranged for her to undergo an illegal abortion. While filming 92 in the Shade, Kidder became romantically involved with Thomas McGuane, and in March 1975, relocated with him to Livingston, Montana. She subsequently became pregnant and gave birth to their only child, a daughter, on October 28, 1975. Kidder and McGuane married on August 2, 1976, but the marriage ended in divorce on July 21, 1977. During the marriage, Kidder stated that her self-esteem had faltered significantly, and she found maintaining a career in film to be difficult while residing in Montana. On August 25, 1979, she married actor John Heard, but the couple separated only six days into their marriage. Their divorce was finalized on December 26, 1980. Kidder was romantically linked to Canadian prime minister Pierre Trudeau in the early 1980s. Kidder married in 1983 French filmmaker Philippe de Broca, who had directed her in Louisiana. Her marriage to de Broca lasted one year, ending in divorce in 1984. Kidder later characterized the marriage as "impulsive, I'm afraid. Not a little irresponsible. We just weren't meant to be married to each other."

Sources: en.wikipedia.org

Supporting material

There are two main application fields of FMO: biochemistry and molecular dynamics of chemical reactions in solution. In addition, there is an emerging field of inorganic applications. In 2005, an application of FMO to the calculation of the ground electronic state of photosynthetic protein with more than 20,000 atoms was distinguished with the best technical paper award at Supercomputing 2005. A number of applications of FMO to biochemical problems has been published, for instance, to Drug design, quantitative structure-activity relationship (QSAR) as well as the studies of excited states and chemical reactions of biological systems. The adaptive frozen orbital (AFO) treatment of the detached bonds was developed for FMO, making it possible to study solids, surfaces and nano systems, such as silicon nanowires. FMO-TDDFT was applied to the excited states of molecular crystals (quinacridone). Among inorganic systems, silica-related materials (zeolites, mesoporous nanoparticles and silica surfaces) were studied with FMO, as well as ionic liquids and boron nitride ribbons. There are other applications of FMO.

Boron (5B) naturally occurs as isotopes 10B and 11B, the latter of which makes up about 80% of natural boron. There are 13 radioisotopes that have been discovered, with mass numbers from 7 to 21, all with short half-lives, the longest being that of 8B, with a half-life of only 771.9(9) ms and 12B with a half-life of 20.20(2) ms. All other isotopes have half-lives shorter than 17.35 ms. Those isotopes with mass below 10 decay into helium via short-lived isotopes of beryllium while those with mass above 11 mostly become carbon.

Exenatide (also Exendin-4, marketed as Byetta) is the first GLP-1 agonist approved for the treatment of type 2 diabetes. Exenatide is not an analogue of GLP but rather a GLP agonist. Exenatide has only 53% homology with GLP, which increases its resistance to degradation by DPP-4 and extends its half-life. A 2011 Cochrane review showed a HbA1c reduction of 0.20% more with Exenatide 2 mg compared to insulin glargine, exenatide 10 μg twice daily, sitagliptin and pioglitazone. Exenatide, together with liraglutide, led to greater weight loss than glucagon-like peptide analogues. Liraglutide, a once-daily human analogue (97% homology), has been developed by Novo Nordisk under the brand name Victoza. The product was approved by the European Medicines Agency (EMEA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010. A 2011 Cochrane review showed a HbA1c reduction of 0.24% more with liraglutide 1.8 mg compared to insulin glargine, 0.33% more than exenatide 10 μg twice daily, sitagliptin and rosiglitazone. Liraglutide, together with exenatide, led to greater weight loss than glucagon-like peptide analogues. Taspoglutide is presently in Phase III clinical trials with Hoffman-La Roche. Lixisenatide (Lyxumia) Sanofi Aventis Semaglutide (Ozempic) (oral version is Rybelsus) Dulaglutide (Trulicity) - once weekly Albiglutide (Tanzeum) - once weekly Tirzepatide - once weekly (dual GLP-1 and GIP agonist; manufactured by Eli Lilly, and approved in 2022.

Prime Minister of Kosovo Official Website (in English) PDK Partia Demokratike e Kosovës (in Albanian) Kryetari Thaçi: Populli i Kosovës dhe UÇK-ja ishin një A Thaçi interview by "Kosova Sot" daily (in Albanian) BBC News Profile Thaçi comments on the future of Kosovo at United States Institute of Peace War crimes cases: Case KSC-BC-2020-06: Hashim Thaçi et al. Case KSC-BC-2023-12: Hashim Thaçi et al. (administration of justice)

Sources: en.wikipedia.org

Frequently asked questions

How should the powder be stored?

Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.

What limits shelf life in solution?

Hydrolysis of peptide bonds and deamidation of arginine and proline residues are the main degradation routes. Alkaline pH and higher temperatures accelerate both processes. Buffered, near-neutral solutions stored cold generally degrade more slowly than unbuffered ones.

Which purity test is most informative?

Reverse-phase chromatography gives the clearest single view of related impurities and truncated sequences. Mass spectrometry then confirms that the main peak carries the expected mass. Neither test detects enantiomeric impurities, which require a separate chiral assay.

What is Selank?

Selank is a synthetic heptapeptide designed as a stabilized analog of the natural tetrapeptide tuftsin. It has been investigated mainly for anxiolytic and cognitive effects. It is not an approved pharmaceutical in most countries.

Network